XHKG
1298
Market cap42mUSD
Jul 09, Last price
1.20HKD
IPO
-50.41%
Name
Yunnan Energy International Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Yunnan Energy International Co. Limited, an investment holding company, distributes analytical and laboratory instruments, and life science equipment in the People’s Republic of China, rest of Asia, and internationally. The company operates in two segments, Distribution Business and Supply Chain Business. It offers analytical instruments, such as medical computed tomography equipment, magnetic resonance imaging systems, fully automated microbial mass spectrometers, digital choledochoscopes, color ultrasound machines, radio frequency therapeutic devices, anesthesia machines, and life monitors, as well as life science and general laboratory instruments with specialized and customized hardware and software to provide solutions and facilitate scientific analysis and testing. It also provides after-sales services, such as testing, training, and maintenance services. In addition, the company engages in trading and supply chain business of construction materials, agricultural products, traditional Chinese medicine products, mineral products, and photovoltaic products. It serves businesses and institutions, which include hospitals, universities, research institutions, and government agencies, as well as companies in the industrial sector. The company was formerly known as Techcomp (Holdings) Limited and changed its name to Yunnan Energy International Co. Limited in December 2018. Yunnan Energy International Co. Limited was founded in 1988 and is headquartered in Wan Chai, Hong Kong. Yunnan Energy International Co. Limited is a subsidiary of Baodi International Investment Company Ltd.
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||